Novel Brentuximab Vedotin Combination Therapies Show Promising Activity in Highly Refractory CD30+ Non-Hodgkin Lymphoma: A Case Series and Review of the Literature

Por Delacruz, Wilfred, Setlik, Robert, Hassantoufighi, Arash, Daya, Shyam, Cooper, Susannah, Selby, Dale, Brown, Alexander
Publicado no Case Rep Oncol Med (2016)

Similar hemostatic responses to hypovolemia induced by hemorrhage and lower body negative pressure reveal a hyperfibrinolytic subset of non-human primates

Por Zaar, Morten, Herzig, Maryanne C., Fedyk, Chriselda G., Montgomery, Robbie K., Prat, Nicolas, Parida, Bijaya K., Hinojosa-Laborde, Carmen, Muniz, Gary W., Shade, Robert E., Bauer, Cassondra, Delacruz, Wilfred, Bynum, James A., Convertino, Victor A., Cap, Andrew P., Pidcoke, Heather F.
Publicado no PLoS One (2020)